The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
VJVirtual | The Route Back to 25 by 25: UKLCC recommendations
Robert Rintoul, MBChB, MRCP, PhD, FRCP, University of Cambridge and Royal Papworth Hospital NHS Foundation Trust, Cambridge, UK; Chair of the UK Lung Cancer Coalition Clinical Advisory Group discusses the recommendations set out in the UKLCC report ‘The Route Back to 25 by 25’, which outlines strategies for achieving 25% 5 year survival by 2025 for patients with lung cancer in the UK. These recommendations include a screening programme, regular public awareness campaigns, and funding for the training of specialist staff across the multidisciplinary team.
